GORE and Heartcare Join Forces to Usher in a New Era of Peripheral Intervention

Introduction

Strategic cooperation to create brilliance together

According to the distribution agreement, the medical products division of Gore China and HeartCare have confirmed their strategic cooperation on peripheral intervention products in China.Gore China will act as the exclusive marketing partner and sales agent for HeartCare's peripheral controllable ciliated coil products in mainland China.Combining the resources and support of both parties to advance the commercialization of this product in China. The distribution agreement provides a valuable opportunity to establish a strategic partnership, and by leveraging each party's business layout, expertise, and resources in the peripheral intervention field, lays a solid foundation for creating synergies in the peripheral intervention sector.

Gore Medical

Gore designs medical products to treat a variety of cardiovascular diseases and other health issues. For over 45 years, more than 55 million devices have been implanted in patients. Through research and development, education, and leading quality, Gore has made significant contributions to improving patient outcomes. Excellent product performance, ease of use, and high-quality service have reduced costs for doctors, hospitals, and insurance companies. Gore collaborates with clinicians to continuously improve patients' lives. For more information, please visit:www.goremedical.com。

Shanghai HeartCare Medical Technology Co., Ltd. is a main board listed company on the Hong Kong Stock Exchange.(Stock Code: 06609.HK)Shanghai HeartCare Medical Technology Co., Ltd. focuses on addressing the unmet clinical needs of doctors and patients in China, committed to enhancing the accessibility of innovative medical technologies and products, reducing mortality rates of severe diseases, improving patient outcomes, and safeguarding life and health. The company’s headquarters is located in the Lingang Special Area of Shanghai, with research and production centers in Zhangjiang (Shanghai), Jiangbei New Area (Nanjing), and California (USA). It also has branches in Beijing, Hong Kong, and other places. The company holds nearly 30 product registration certificates for domestically produced medical devices in China, owns over 200 authorized patents, and two of its products have received the national "Priority Review for Innovative Medical Devices" qualification.